Found 50 results
Author Title Type [ Year(Asc)]
Filters: Author is Lindblad, R  [Clear All Filters]
2014
E. McClure, Sonne, S., Winhusen, T., Carroll, K., Ghitza, U., McRae-Clark, A., Matthews, A., Sharma, G., Van Veldhuisen, P., Vandrey, R., Levin, F., Weiss, R., Lindblad, R., Allen, C., Mooney, L., Haynes, L., Brigham, G., Sparenborg, S., Hasson, A., and Gray, K., Achieving Cannabis Cessation – Evaluating N-Acetylcysteine Treatment (ACCENT): Design and Implementation of a Multi-Site, Randomized Controlled Study in the National Institute on Drug Abuse Clinical Trials Network, Contemp Clin Trials, vol. 39, pp. 211-223, 2014.
M. P. Bogenschutz, Donovan, D. M., Mandler, R. N., Perl, H. I., Forcehimes, A. A., Crandall, C., Lindblad, R., Oden, N. L., Sharma, G., Metsch, L., Lyons, M. S., McCormack, R., Konstantopoulos, W. M., and Douaihy, A., Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments: A Randomized Clinical Trial, JAMA Intern Med, vol. 174, pp. 1736-1745, 2014.
L. Kottyan, Davis, B., Sherrill, J., Liu, K., Rochman, M., Kaufman, K., Weirauch, M., Vaughn, S., Lazaro, S., Rupert, A., Kohram, M., Stucke, E., Kemme, K., ,, Lindblad, R., Sampson, H., Mukkada, V., Putnam, P., Abonia, J., Martin, L., Harley, J., and Rothenberg, M., Genome-Wide Association Analysis of Eosinophilic Esophagitis Provides Insight Into the Tissue Specificity of This Allergic Disease, Nat Genet, vol. 46, pp. 895-900, 2014.
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., VanVeldhuisen, P., Theobald, J., May, J., and Brigham, G. S., Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence, J Clin Psychiatry, vol. 75, pp. 757-764, 2014.
B. Tai, Hu, L., Ghitza, U. E., Sparenborg, S., Van Veldhuisen, P., and Lindblad, R., Patient Registries for Substance Use Disorders, Subst Abuse Rehabil, vol. 5, pp. 81-86, 2014.
2013
L. J. Mooney, Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., and Ling, W., Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology, Contemp Clin Trials, vol. 34, pp. 196-204, 2013.
U. Ghitza, Gore-Langton, R., Lindblad, R., Shide, D., Subramanian, G., and Tai, B., Common Data Elements for Substance Use Disorders in Electronic Health Records: The NIDA Clinical Trials Network Experience, Addiction, vol. 108, pp. 3-8, 2013.
R. Lindblad, McCormack, J., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Mooney, L., Van Veldhuisen, P., and Ling, W., Induction onto Extended-release Naltrexone in 302 Cocaine-dependent Opioid Users, in College on Problems of Drug Dependence Meeting, San Diego CA, 2013.
R. A. Wood, Sicherer, S. H., Burks, A. W., Grishin, A., Henning, A. K., Lindblad, R., Stablein, D., and Sampson, H. A., A Phase 1 Study of Heat/Phenol-Killed, E. coli - Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy, Allergy, vol. 68, pp. 803-808, 2013.
R. A. Wood, Sicherer, S. H., Burks, A. W., Grishin, A., Henning, A. K., Lindblad, R., Stablein, D., and Sampson, H. A., A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy., Allergy, vol. 68, no. 6, pp. 803-8, 2013.
B. Tai, Gore-Langton, R. E., Ghitza, U. E., Lindblad, R., Subramaniam, G., and Shide, D., Response to Commentaries, Addiction, vol. 108, pp. 12-13, 2013.
D. M. Fleischer, Burks, A. W., Vickery, B. P., Scurlock, A. M., Wood, R. A., Jones, S. M., Sicherer, S. H., Liu, A. H., Stablein, D., Henning, A. K., Mayer, L., Lindblad, R., Plaut, M., and Sampson, H. A., Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial, J Allergy Clin Immunol, vol. 131, pp. 119-127.e1-7, 2013.
R. Lindblad, Quinnan, K., and Wood, D., A Successful Support Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group, Transfusion, vol. 53, p. Supplement AP34, 2013.
R. Lindblad, Styers, D., and Wood, D., A Successful Web Seminar Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group, in AABB Annual Meeting & TXPO, Denver, CO, Denver, CO, 2013, No. 2S., vol. 53, p. Supplement AP40.
2012
R. Lindblad, Campanella, M., Van Veldhuisen, P., and Allen, C., Clinical Trial Management: Monitoring Progress, Sites and Safety; New Paradigms for Efficiency, in 5th Annual Clinical Research Management Workshop at the Yale Center for Clinical Investigation, New Haven, CT, 2012.
S. H. Sicherer, Stablein, D., Wood, R. A., Burks, A. W., Liu, A. H., Jones, S. M., Fleischer, D. M., Mayer, L., Lindblad, R., Grishin, A., and Sampson, H. A., Consortium of Food Allergy Research (CoFAR). Relationship of Cytokine and regulatory Gene Expression to the Outcomes of Milk and Egg Allergy in an Atopic Cohort., in AAAAI - American Academy of Allergy, Asthma & Immunology, Orlando, FL, 2012, vol. 125, p. AB25.
T. M. Winhusen, Stitzer, M. L., Woody, G. E., Brigham, G. S., Kropp, F. B., Ghitza, U., Lindblad, R., Adinoff, B., Green, C., Sharma, G., and Somoza, E., Design Considerations for a Study to Evaluate the Impact of Smoking Cessation Treatment on Stimulant Use Outcomes in Stimulant-Dependent Individuals, Contemp Clin Trials, vol. 33, pp. 197-205, 2012.
R. Lindblad, Hu, L., Campanella, M., Kondapaka, R., Rosa, C., Allen, C., Oden, N., and Van Veldhuisen, P., Estimating Death Rates In Substance Use Disorder, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., Van Veldhuisen, P., Adinoff, B., and Somoza, E., Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World, Contemp Clin Trials, vol. 33, pp. 993-1002, 2012.
A. W. Burks, Jones, S. M., Wood, R. A., Fleischer, D. M., Sicherer, S. H., Lindblad, R., Stablein, D., Henning, A. K., Vickery, B. P., Liu, A. H., Scurlock, A. M., Shreffler, W. G., Plaut, M., Sampson, H. A., and CoFAR), Cof Food Al, Oral Immunotherapy for Treatment of Egg Allergy in Children, N Engl J Med, vol. 367, pp. 233-243, 2012.
R. A. Wood, Stablein, D., Henning, A. K., Lindblad, R., and Sicherer, S. H., A Phase 1 Study of Heat/Phenol Killed, E. coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy, in AAAAI - American Academy of Allergy, Asthma & Immunology, Orlando, FL, 2012, vol. 129(2), p. AB27.
D. M. Fleischer, Wood, R. A., Jones, S. M., Sicherer, S. H., Liu, A. H., Stablein, D., Henning, A., Mayer, L., Lindblad, R., and Sampson, H. A., Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial, in AAAAI - American Academy of Allergy, Asthma & Immunology, 2012, vol. 129(2), p. AB66.